Heart Failure and Cardiomyopathies

Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension Refined Heart Failure Stages Incorporating Cardiorespiratory Fitness Are Differentially Associated With Heart Failure Risk in the Community Will Evaluation of Cardiorespiratory Fitness Improve Risk Stratification of Patients With Stage B Heart Failure? Carfilzomib-Induced Cardiogenic Shock: A Reversible But Life-Threatening Complication Mapping of Early Exercise‐Based Interventions for Patients Recovering From Acute Heart Failure: A Scoping Review Preclinical Heart Failure: A Dynamic Trajectory of Progression, Regression, and Risk Cardiogenic Shock Detection Using Electronic Medical Records: A Review and Blueprint for Clinical Implementation and Future Research Clinical Implications of Left Atrial and Ventricular Reverse Remodeling After Atrial Fibrillation Ablation in Patients With Systolic Dysfunction Burden of Potentially Undiagnosed Heart Failure With Preserved Ejection Fraction in Atrial Fibrillation and Effects of Catheter Ablation: Insights From CABANA Empagliflozin Attenuates Cardiac Fibrosis by Suppressing Fibroblast‐Mediated C‐C Motif Chemokine Ligand 2 Expression